Red Nucleus Interleukin-6 Evokes Tactile Allodynia in Male Rats Through Modulating Spinal Pro-inflammatory and Anti-inflammatory Cytokines.

allodynia interleukin-10 interleukin-1β interleukin-6 red nucleus spinal cord transforming growth factor-β tumor necrosis factor-α

Journal

Frontiers in molecular neuroscience
ISSN: 1662-5099
Titre abrégé: Front Mol Neurosci
Pays: Switzerland
ID NLM: 101477914

Informations de publication

Date de publication:
2022
Historique:
received: 23 11 2021
accepted: 04 03 2022
entrez: 25 4 2022
pubmed: 26 4 2022
medline: 26 4 2022
Statut: epublish

Résumé

Our previous studies have clarified that red nucleus (RN) interleukin (IL)-6 is involved in the maintenance of neuropathic pain and produces a facilitatory effect by activating JAK2/STAT3 and ERK pathways. In this study, we further explored the immune molecular mechanisms of rubral IL-6-mediated descending facilitation at the spinal cord level. IL-6-evoked tactile allodynia was established by injecting recombinant IL-6 into the unilateral RN of naive male rats. Following intrarubral administration of IL-6, obvious tactile allodynia was evoked in the contralateral hindpaw of rats. Meanwhile, the expressions of pro-inflammatory cytokines tumor necrosis factor-α (TNF-α), IL-1β, and IL-6 were elevated in the contralateral spinal dorsal horn (L4-L6), blocking spinal TNF-α, IL-1β, or IL-6 with neutralizing antibodies relieved IL-6-evoked tactile allodynia. Conversely, the levels of anti-inflammatory cytokines transforming growth factor-β (TGF-β) and IL-10 were reduced in the contralateral spinal dorsal horn (L4-L6), an intrathecal supplement of exogenous TGF-β, or IL-10 attenuated IL-6-evoked tactile allodynia. Further studies demonstrated that intrarubral pretreatment with JAK2/STAT3 inhibitor AG490 suppressed the elevations of spinal TNF-α, IL-1β, and IL-6 and promoted the expressions of TGF-β and IL-10 in IL-6-evoked tactile allodynia rats. However, intrarubral pretreatment with ERK inhibitor PD98059 only restrained the increase in spinal TNF-α and enhanced the expression of spinal IL-10. These findings imply that rubral IL-6 plays descending facilitation and produces algesic effect through upregulating the expressions of spinal pro-inflammatory cytokines TNF-α, IL-1β, and IL-6 and downregulating the expressions of spinal anti-inflammatory cytokines TGF-β and IL-10 by activating JAK2/STAT3 and/or ERK pathways, which provides potential therapeutic targets for the treatment of pathological pain.

Identifiants

pubmed: 35465093
doi: 10.3389/fnmol.2022.820664
pmc: PMC9026175
doi:

Types de publication

Journal Article

Langues

eng

Pagination

820664

Informations de copyright

Copyright © 2022 Yang, Li, Xia, Tian, Feng, Yang, Xu, Guo, Li, Wang and Zeng.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Neurochem Res. 2016 Nov;41(11):3042-3051
pubmed: 27485712
J Headache Pain. 2019 Nov 11;20(1):104
pubmed: 31711434
Arthritis Rheum. 2007 Jan;56(1):351-9
pubmed: 17195239
J Pain. 2020 May - Jun;21(5-6):731-741
pubmed: 31733364
Handb Clin Neurol. 2018;159:3-26
pubmed: 30482322
Nat Commun. 2019 May 21;10(1):2241
pubmed: 31113944
Mol Pain. 2016 May 12;12:
pubmed: 27175012
Nat Rev Genet. 2020 Oct;21(10):630-644
pubmed: 32709985
Eur J Pain. 2009 Oct;13(9):915-23
pubmed: 19095475
Brain Res. 2012 Sep 14;1473:124-30
pubmed: 22877853
J Pharmacol Exp Ther. 2020 Oct;375(1):202-209
pubmed: 32114512
Exp Neurol. 2018 Feb;300:212-221
pubmed: 29183675
Mol Brain. 2020 Jul 28;13(1):106
pubmed: 32723345
Pain. 2000 May;86(1-2):63-8
pubmed: 10779661
Aging (Albany NY). 2021 Apr 23;13(10):13615-13625
pubmed: 33893246
Behav Brain Res. 1992 Nov 30;52(1):29-44
pubmed: 1472285
Curr Pain Headache Rep. 2005 Aug;9(4):281-8
pubmed: 16004846
Brain Behav Immun. 2020 Nov;90:145-154
pubmed: 32791212
Neuroscience. 2015 Apr 16;291:37-45
pubmed: 25662509
Cytokine. 2005 May 21;30(4):154-9
pubmed: 15863388
Korean J Pain. 2021 Apr 01;34(2):176-184
pubmed: 33785669
J Neurosci. 2002 Apr 15;22(8):3052-60
pubmed: 11943808
Pain. 2011 Oct;152(10):2204-2205
pubmed: 21764514
Exp Neurol. 2011 Mar;228(1):30-40
pubmed: 21075106
Neuropathology. 2020 Aug;40(4):347-357
pubmed: 32380573
Exp Neurol. 2001 Jun;169(2):386-91
pubmed: 11358451
Neurosci Lett. 2007 Mar 19;415(1):1-5
pubmed: 17222972
J Neurosci. 2008 Oct 15;28(42):10482-95
pubmed: 18923025
Pain. 2010 Nov;151(2):345-355
pubmed: 20709454
Brain Struct Funct. 2012 Apr;217(2):221-32
pubmed: 21927901
Brain Res. 1995 Sep 18;692(1-2):123-8
pubmed: 8548295
J Neurosci. 2017 Jan 25;37(4):871-881
pubmed: 28123022
Mol Pain. 2012 Jan 24;8:6
pubmed: 22273495
Acta Neurobiol Exp (Wars). 2014;74(4):424-32
pubmed: 25576973
J Neurosci. 2003 Feb 1;23(3):1026-40
pubmed: 12574433
Eur Spine J. 2002 Oct;11(5):467-75
pubmed: 12384756
J Neurochem. 2008 Oct;107(1):50-60
pubmed: 18636982
J Neurosci. 2016 Sep 21;36(38):9782-91
pubmed: 27656018
J Pain. 2013 Dec;14(12):1671-85
pubmed: 24290447
Brain Res. 1991 Aug 9;556(1):78-84
pubmed: 1682007
Brain Res. 2010 Mar 8;1318:11-22
pubmed: 20060814
Nat Immunol. 2015 May;16(5):448-57
pubmed: 25898198
J Neurosci. 2010 Oct 27;30(43):14533-42
pubmed: 20980611
Pain. 2011 Feb;152(2):419-427
pubmed: 21159431
J Neuroinflammation. 2016 Jun 07;13(1):141
pubmed: 27267059
J Leukoc Biol. 2020 Nov;108(5):1575-1592
pubmed: 32573822
J Neurosci Methods. 2001 Oct 15;111(1):49-57
pubmed: 11574119
Neurochem Res. 2012 Aug;37(8):1811-9
pubmed: 22584848
J Comp Neurol. 2002 Jul 8;448(4):349-59
pubmed: 12115698
J Interferon Cytokine Res. 1996 Sep;16(9):695-700
pubmed: 8887053
Exp Brain Res. 2000 Mar;131(2):215-24
pubmed: 10766273
BMJ. 2014 Feb 05;348:f7656
pubmed: 24500412
Mol Pain. 2014 Jul 04;10:45
pubmed: 24993495
Brain Res Bull. 2008 Nov 25;77(5):233-6
pubmed: 18824078
J Neuroinflammation. 2021 Jul 5;18(1):150
pubmed: 34225736
Exp Neurol. 2013 Mar;241:159-68
pubmed: 23261764
Nat Rev Drug Discov. 2014 Jul;13(7):533-48
pubmed: 24948120
Pain. 2002 Sep;99(1-2):313-21
pubmed: 12237210
Exp Brain Res. 2008 Jul;188(3):379-84
pubmed: 18431565
Neuron Glia Biol. 2010 Feb;6(1):73-83
pubmed: 20519054
Brain Behav Immun. 2018 Oct;73:504-519
pubmed: 29928964
Integr Cancer Ther. 2018 Jun;17(2):401-410
pubmed: 28870114
Pain. 2015 Jun;156(6):1124-1144
pubmed: 25775359
Science. 2016 Nov 4;354(6312):578-584
pubmed: 27811268

Auteurs

Qing-Qing Yang (QQ)

Department of Laboratory Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Department of Pathogenic Biology and Immunology, Xi'an Jiaotong University Health Science Center, Xi'an, China.

Hao-Nan Li (HN)

Department of Pathogenic Biology and Immunology, Xi'an Jiaotong University Health Science Center, Xi'an, China.

Yu-Tong Xia (YT)

Department of Pathogenic Biology and Immunology, Xi'an Jiaotong University Health Science Center, Xi'an, China.

Xue Tian (X)

Department of Pathogenic Biology and Immunology, Xi'an Jiaotong University Health Science Center, Xi'an, China.

Fan Feng (F)

Department of Pathogenic Biology and Immunology, Xi'an Jiaotong University Health Science Center, Xi'an, China.

Jian Yang (J)

Department of Pathogenic Biology and Immunology, Xi'an Jiaotong University Health Science Center, Xi'an, China.

Ya-Li Xu (YL)

Department of Pathogenic Biology and Immunology, Xi'an Jiaotong University Health Science Center, Xi'an, China.

Juan Guo (J)

Department of Pathogenic Biology and Immunology, Xi'an Jiaotong University Health Science Center, Xi'an, China.

Xiao-Qi Li (XQ)

Department of Pathogenic Biology and Immunology, Xi'an Jiaotong University Health Science Center, Xi'an, China.

Jun-Yang Wang (JY)

Department of Pathogenic Biology and Immunology, Xi'an Jiaotong University Health Science Center, Xi'an, China.

Xiao-Yan Zeng (XY)

Department of Laboratory Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.

Classifications MeSH